Pharmafile Logo

payer survey

- PMLiVE

Eli Lilly signs agreement worth up to $600m for Confo Therapeutics’ non-opioid pain candidate

Neuropathic pain results from conditions including multiple sclerosis, diabetes, shingles or cancer

- PMLiVE

AstraZeneca announces major expansion of Canadian research footprint

The investment includes the creation of 500 jobs and a new rare disease research hub

- PMLiVE

BioNTech and Weizmann Institute to collaborate at company’s new mRNA centre in Israel

The research facility is expected to start operations by the end of the year

Lianne’s Story – Supporting Deaf People With Their Mental Health

Take a look at how we helped a member of our team to achieve her goal of providing more support to the Deaf community

Mednet

Introduction to Origins

In this short video Mark Corbett, Chief Innovation Officer at Resonant Group, gives a brief introduction to Origins, the patient focused specialist agency.If you'd like to know more, visit the...

Origins – The Patient Focused Specialists

Streamlining Healthcare Delivery Through Digital Care Journeys

Dr. Joshua Liu, Co-founder & CEO of SeamlessMD, explores how technology and “Digital Care Journeys” can help hospitals reduce the surgical backlog for high-volume procedures like hip and knee replacements,...

Impetus Digital

- PMLiVE

Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children

The vaccine is already authorised as the third of a three-dose primary series in this age group

- PMLiVE

ABPI sets out proposals for UK government to support the NHS and economy

The association is suggesting a fixed rebate rate of 6.88% on all eligible UK drug sales

- PMLiVE

Ketchum appoints Conor Nash as global chief financial officer and chief operating officer

Nash was most recently Ogilvy’s chief operating officer in North America

- PMLiVE

Eli Lilly announces 70% cut to US insulin prices while also capping out-of-pocket costs

Insulin manufacturers have come under fire recently over the cost of their insulin products

- PMLiVE

WHO announces recommended 2023-24 flu vaccines for northern hemisphere

The constantly evolving nature of influenza viruses requires frequent reformulation of vaccines

- PMLiVE

Pfizer’s RSV vaccine candidate for older adults backed by FDA Advisory Committee

RSV infections in older adults account for 60,000 to 160,000 hospitalisations each year in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links